INFLIXIMAB, INFLIXIMAB clinical trials

Impact of early proactive therapeutic drug monitoring on the durability and efficacy of infliximab therapy in pediatric inflammatory bowel disease: a multicenter open-label randomized-control trial

This study looks at children and teenagers with Inflammatory Bowel Disease who are starting treatment with a medicine called infliximab. Researchers want to see if checking medicine levels early helps the treatment work better and for longer, compared to usual care.